Medicare Price Negotiation “Not A Priority” For House Dems
This article was originally published in The Pink Sheet Daily
Executive Summary
Medicaid rebate increase and follow-on biologics could take $70 billion from pharma over 10 years, key staffer says—but industry should be happy with that trade.